Pages that link to "Q59079703"
Jump to navigation
Jump to search
The following pages link to Interleukin-2 augments natural killer cell activity (Q59079703):
Displaying 50 items.
- Soluble metals in residual oil fly ash alter innate and adaptive pulmonary immune responses to bacterial infection in rats (Q23914723) (← links)
- Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes (Q24298467) (← links)
- IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation (Q24629447) (← links)
- Novel immunotherapeutic approaches to the treatment of urothelial carcinoma (Q26744347) (← links)
- Evolving immunotherapy strategies in urothelial cancer (Q26823557) (← links)
- "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy (Q28081338) (← links)
- Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model (Q28539632) (← links)
- Biology of natural killer cells (Q29619728) (← links)
- Distinct Migration and Contact Dynamics of Resting and IL-2-Activated Human Natural Killer Cells. (Q30441681) (← links)
- In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. (Q33639596) (← links)
- The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta (Q33832658) (← links)
- Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation (Q33893091) (← links)
- Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon (Q33912513) (← links)
- Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo (Q34078028) (← links)
- Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. (Q34329668) (← links)
- Natural killer cells and nitric oxide. (Q34342650) (← links)
- Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity (Q34502870) (← links)
- Lysis of primary hepatic tumours by lymphokine activated killer cells (Q34527814) (← links)
- Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells (Q34527846) (← links)
- Enhancement of natural killer function through activation of the T11 E rosette receptor (Q34556806) (← links)
- Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells (Q34565223) (← links)
- Natural killer cells are present in the normal human lung but are functionally impotent (Q34614312) (← links)
- Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro (Q34627351) (← links)
- Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes (Q34630635) (← links)
- IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells (Q34651540) (← links)
- NK cells and their ability to modulate T cells during virus infections (Q34700499) (← links)
- The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3. (Q34709277) (← links)
- Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytes (Q34729463) (← links)
- Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases. (Q34901832) (← links)
- Clinical applications of interleukin-2 (Q35223913) (← links)
- Determination of natural killer cell function by flow cytometry. (Q35226752) (← links)
- Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells (Q35585247) (← links)
- Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase (Q35594188) (← links)
- Natural killer cells and cancer (Q35622883) (← links)
- Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics (Q35664711) (← links)
- Soluble interleukin 2 receptor in atopic eczema (Q35712107) (← links)
- A brief survey of pineal gland-immune system interrelationships (Q35785665) (← links)
- IL-2 mRNA expression in Tac-positive malignant lymphomas (Q35811193) (← links)
- Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2 (Q35823805) (← links)
- IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment (Q35885490) (← links)
- Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy (Q35939155) (← links)
- Immunological studies in patients with HBsAg-positive chronic active hepatitis--spontaneous lymphocyte transformation and natural killer cell activity (Q35948405) (← links)
- A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects (Q35976681) (← links)
- Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: Evidence for interferon- and interleukin 2-independent NK cell activation (Q35991832) (← links)
- Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck (Q35994118) (← links)
- Bladder Cancer Immunotherapy: BCG and Beyond. (Q36072179) (← links)
- Adenoviral vectors: development and application (Q36179657) (← links)
- Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. (Q36258532) (← links)
- Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes (Q36259822) (← links)
- Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. (Q36266999) (← links)